Nanjing Vishee Medical Technology Co., Ltd (688580.SS)
CNY 35.1
(-2.15%)
CNY 35.1
(-2.15%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 148.44 Million CNY | 42.11% |
| 2022 | 104.45 Million CNY | -46.34% |
| 2021 | 194.67 Million CNY | 18.09% |
| 2020 | 164.86 Million CNY | 43.76% |
| 2019 | 114.67 Million CNY | 59.24% |
| 2018 | 72.01 Million CNY | 53.72% |
| 2017 | 46.84 Million CNY | 130.31% |
| 2016 | 20.34 Million CNY | -14.68% |
| 2015 | 23.84 Million CNY | 39.05% |
| 2014 | 17.14 Million CNY | 122.2% |
| 2013 | 7.71 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 31.5 Million CNY | 61.91% |
| 2024 Q1 | 22.62 Million CNY | -38.7% |
| 2024 Q2 | 19.45 Million CNY | -14.0% |
| 2023 Q3 | 34.67 Million CNY | -22.27% |
| 2023 FY | 148.44 Million CNY | 42.11% |
| 2023 Q4 | 36.9 Million CNY | 6.45% |
| 2023 Q2 | 44.6 Million CNY | 38.29% |
| 2023 Q1 | 32.25 Million CNY | -15.38% |
| 2022 Q2 | 23.74 Million CNY | 49.08% |
| 2022 Q1 | 15.92 Million CNY | -78.85% |
| 2022 Q4 | 38.11 Million CNY | 42.96% |
| 2022 FY | 104.45 Million CNY | -46.34% |
| 2022 Q3 | 26.66 Million CNY | 12.28% |
| 2021 FY | 194.67 Million CNY | 18.09% |
| 2021 Q1 | 33.21 Million CNY | -50.64% |
| 2021 Q2 | 42.8 Million CNY | 28.87% |
| 2021 Q3 | 43.35 Million CNY | 1.27% |
| 2021 Q4 | 75.3 Million CNY | 73.72% |
| 2020 Q3 | 37.32 Million CNY | -9.65% |
| 2020 Q1 | 18.93 Million CNY | -45.35% |
| 2020 Q4 | 67.29 Million CNY | 80.32% |
| 2020 Q2 | 41.3 Million CNY | 118.14% |
| 2020 FY | 164.86 Million CNY | 43.76% |
| 2019 Q3 | 31.44 Million CNY | 8.57% |
| 2019 Q4 | 34.64 Million CNY | 10.17% |
| 2019 Q2 | 28.96 Million CNY | 47.71% |
| 2019 Q1 | 19.61 Million CNY | 0.0% |
| 2019 FY | 114.67 Million CNY | 59.24% |
| 2018 FY | 72.01 Million CNY | 53.72% |
| 2017 FY | 46.84 Million CNY | 130.31% |
| 2016 Q1 | 5.32 Million CNY | 0.0% |
| 2016 FY | 20.34 Million CNY | -14.68% |
| 2016 Q2 | 5.32 Million CNY | 0.0% |
| 2015 Q1 | 4.22 Million CNY | 0.0% |
| 2015 FY | 23.84 Million CNY | 39.05% |
| 2015 Q2 | 4.22 Million CNY | 0.0% |
| 2014 FY | 17.14 Million CNY | 122.2% |
| 2013 FY | 7.71 Million CNY | 0.0% |